Bionik Laboratories Corp.·4

Jan 26, 3:51 PM ET

MARKOW LESLIE NADENE 4

4 · Bionik Laboratories Corp. · Filed Jan 26, 2018

Insider Transaction Report

Form 4
Period: 2018-01-24
MARKOW LESLIE NADENE
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-01-24+300,000300,000 total
    Exercise: $0.15Exp: 2028-01-24Common Stock, par value $0.001 (300,000 underlying)
Footnotes (1)
  • [F1]The options vest 100,000 on January 24, 2019, 100,000 on January 24, 2020 and 100,000 on January 24, 2021.

Documents

1 file
  • 4
    tv484159_4.xmlPrimary

    OWNERSHIP DOCUMENT